Archived Science Blog page from 2016. It stays on Science Blog so the original link still works. It is not a current article. Back to Science Blog
Science Blog -- FDA APPROVES NEW ORAL FLU DRUG
a new oral drug to combat influenza A, the most serious form of
alleviate flu symptoms in adults. In addition, it can be used in
some situations to prevent influenza A in both children and adults;
however, vaccines remain the method of choice for preventing flu.
symptoms begin. The drug is taken twice a day for at least 7 days
after onset of symptoms. Rimantadine has not been proven safe and
effective for treating symptoms in children and is labeled as a
protects against influenza A in both children and adults. It is
useful for patients who cannot tolerate vaccines -- for example,
people who are allergic to vaccine components or who are taking
drugs that suppress the immune system. However, the drug has not
been proven safe to take for more than 6 weeks and does not protect
against influenza B, another common flu strain. In addition, a
study has shown that use of rimantadine for both prevention and
treatment in the same setting -- for example, a single household --
may result in transmission of drug-resistant strains of the virus.
method for preventing flu, according to the Centers for Disease
another oral flu drug, rimantadine caused fewer side effects. In
a six-week prevention study in 436 healthy adults, 14.7 percent of
those taking amantadine had adverse reactions, compared to 6.9
percent of those taking rimantadine. The most common side effects
affected by flu and some 20,000 die, 90 percent of them elderly.
Influenza A is not usually life-threatening but can be dangerous in
the elderly and in people with chronic illnesses and other health
problems. Of the two main types -- influenza A and B -- influenza
Rimantadine, marketed as Flumadine, is available as a 100 mg.